BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 15246157)

  • 1. A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cells.
    Harada H; Watanabe S; Saijo K; Ishiwata I; Ohno T
    Exp Hematol; 2004 Jul; 32(7):614-21. PubMed ID: 15246157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of immunomagnetic methods used for separation of human natural killer cells from peripheral blood.
    Øren A; Husebø C; Iversen AC; Austgulen R
    J Immunol Methods; 2005 Aug; 303(1-2):1-10. PubMed ID: 16054641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation between the percent of CD3- CD56+ cells and NK precursor function.
    Gharehbaghian A; Donaldson C; Newman J; Bannister G; Bradley BA
    Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):167-75. PubMed ID: 17237569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
    Condiotti R; Nagler A
    Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective expansion of human natural killer cells from peripheral blood mononuclear cells by the cell line, HFWT.
    Harada H; Saijo K; Watanabe S; Tsuboi K; Nose T; Ishiwata I; Ohno T
    Jpn J Cancer Res; 2002 Mar; 93(3):313-9. PubMed ID: 11927014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selective expansion of human natural killer cells].
    Peng BG; Liang LJ; He Q; Li J; Lu MD
    Ai Zheng; 2005 Oct; 24(10):1287-9. PubMed ID: 16219151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
    Baume DM; Robertson MJ; Levine H; Manley TJ; Schow PW; Ritz J
    Eur J Immunol; 1992 Jan; 22(1):1-6. PubMed ID: 1370410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective expansion and engraftment of human CD16+ NK cells in NOD/SCID mice.
    Harada H; Suzu S; Ito T; Okada S
    Eur J Immunol; 2005 Dec; 35(12):3599-609. PubMed ID: 16304638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
    Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
    Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone.
    Hayakawa K; Salmeron MA; Kornbluth J; Bucana C; Itoh K
    J Immunol; 1991 Apr; 146(7):2453-60. PubMed ID: 1900882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J
    Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
    Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
    Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo expansion of natural killer cells for clinical applications.
    Klingemann HG; Martinson J
    Cytotherapy; 2004; 6(1):15-22. PubMed ID: 14985163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
    Bose A; Baral R
    Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulatory signals are required for optimal proliferation of human natural killer cells.
    Robertson MJ; Manley TJ; Donahue C; Levine H; Ritz J
    J Immunol; 1993 Mar; 150(5):1705-14. PubMed ID: 7679691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
    Lin SJ; Kuo ML
    Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-7 selectively enhances natural kill cytotoxicity mediated by the CD56bright natural killer subpopulation.
    Dadmarz R; Bockstoce DC; Golub SH
    Lymphokine Cytokine Res; 1994 Dec; 13(6):349-57. PubMed ID: 7535569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines.
    Perussia B; Ramoni C; Anegon I; Cuturi MC; Faust J; Trinchieri G
    Nat Immun Cell Growth Regul; 1987; 6(4):171-88. PubMed ID: 2960890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion and activation of natural killer cells from PBMC for immunotherapy of hepatocellular carcinoma.
    Peng BG; Liang LJ; He Q; Huang JF; Lu MD
    World J Gastroenterol; 2004 Jul; 10(14):2119-23. PubMed ID: 15237448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and cytolytic activity of Macaca nemestrina natural killer cells isolated from blood and expanded in vitro.
    Shields LE; Sieverkropp AJ; Potter J; Andrews RG
    Am J Primatol; 2006 Aug; 68(8):753-64. PubMed ID: 16847969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.